Dr. Martin Kampmann outlines a new strategy to investigate neurodegenerative diseases in a Perspective in press at Trends in Molecular Medicine. He co-developed a research platform based on CRISPR technology that enables activation and repression of each gene in human cells. This platform paves the way for a systematic elucidation of cellular factors that control neurodegeneration. Such factors are potential therapeutic targets in neurodegenerative diseases including Alzheimer’s Disease and Parkinson’s Disease.
Read the perspective here (https://www.ncbi.nlm.nih.gov/pubmed/28478951) or contact us for a copy.
(Image credit: Connor Ludwig, Kampmann Lab)